This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE PRO (Alcon Laboratories, Inc.) to MIEBO (Bausch + Lomb) in treating symptoms of evaporative dry eye disease (DED). The primary goal is to determine whether SYSTANE PRO is non-inferior to MIEBO after one month of treatment, based on change in Ocular Surface Disease Index (OSDI) scores.